Silicate Nanoparticles for Cartilage Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for cartilage damage within joints are limited and often result in side effects such as inflammatory responses, tumor formation, and high costs due to the use of supraphysiological doses of growth factors like BMP-2 and TGF-β1, which have limited clinical efficacy and significant complications.
Innovation Solution
Mineral-based nanoparticles, specifically silicate nanoparticles, are used to induce human mesenchymal stem cells into a cartilage-lineage by upregulating cartilage-specific genes, transforming them into chondrocytes, and are incorporated into polymeric matrices or directly injected into joints for localized delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If supraphysiological doses of growth factors (BMP-2, TGF-β1) are used to stimulate cartilage formation, then cartilage production is enhanced, but inflammatory responses, tumor formation, and other harmful side effects occur
Solution Approach 1:
The patent changes the fundamental parameter from using supraphysiological doses of growth factors to using physiological doses combined with mineral-based nanoparticles. This parameter change allows achieving cartilage formation efficacy while avoiding the harmful side effects associated with high-dose growth factor therapy.
Solution Approach 2:
The patent introduces mineral-based nanoparticles (calcium phosphite, calcium silicate, magnesium silicate) as intermediary carriers that deliver growth factors in a controlled manner. These nanoparticles act as mediators between the growth factors and target cells, enabling physiological dosing while maintaining therapeutic efficacy through localized delivery and controlled release.
2Productivity
If BMP-2 is delivered via liposome encapsulation to induce cartilage formation, then cartilage formation is achieved at the defect site, but the short half-life (7-16 minutes) and susceptibility to proteinases require supraphysiological doses
Solution Approach 1:
The patent uses composite mineral-based nanoparticle materials (calcium phosphite, calcium silicate, magnesium silicate) that combine structural stability with controlled release properties. These composite materials protect encapsulated growth factors from degradation by proteinases and provide sustained release over time, eliminating the need for supraphysiological dosing.
Solution Approach 2:
The patent replaces the short-lived liposome carriers with more stable mineral-based nanoparticle carriers that have extended half-life and resistance to enzymatic degradation. This substitution allows the growth factors to remain active longer and reach their target effectively at physiological doses.
3Reliability
If high concentrations of growth factors are administered to achieve therapeutic efficacy, then cartilage regeneration is stimulated, but uncontrolled tissue formation, inflammation, neurological events, and carcinogenicity occur
Solution Approach 1:
The patent applies local quality by using mineral-based nanoparticles for localized delivery of growth factors directly to the cartilage defect site. This localized delivery ensures high concentration at the target site for therapeutic efficacy while maintaining low systemic concentration, thereby avoiding uncontrolled tissue formation and carcinogenicity in non-target areas.
Solution Approach 2:
The mineral-based nanoparticles serve as intermediary carriers that control the release kinetics and localization of growth factors. This intermediary system ensures that growth factors are delivered precisely where needed at appropriate concentrations, preventing both insufficient efficacy and harmful overstimulation in surrounding tissues.
4Productivity
If other growth factors (TGF-β1) are used to stimulate cartilage growth, then some cartilage production is achieved, but tumor growth, edema, and inflammatory responses are triggered
Solution Approach 1:
The patent changes the dosing parameter from supraphysiological to physiological concentrations of growth factors, combined with mineral nanoparticle delivery. This parameter change reduces the risk of tumor growth and edema while maintaining cartilage growth stimulation through enhanced local delivery efficiency.
Solution Approach 2:
The mineral-based nanoparticles act as intermediary delivery systems that enable physiological dosing of growth factors like TGF-β1 to achieve therapeutic cartilage growth without triggering harmful effects. The nanoparticles control release kinetics and localize the growth factor action, preventing systemic side effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The silicate nanoparticles promote cartilage regeneration with minimal side effects, enhance mechanical properties of hydrogels, and enable reduced growth-factor concentrations, providing a safe and effective alternative for cartilage tissue repair.
Implementation Method 1
Cellular internalization of SiNPs was blocked using the clathrin vesicle inhibitor, chlorpromazine
Implementation Method 2
Ionic dissolution products from inorganic materials play an important role in controlling a variety of biological functions
Implementation Method 3
Specifically, for cartilage synthesis, orthosilicic acid (Si(OH)4) has been shown to enhance collagen synthesis and Ca metabolism via increasing serum Si levels
Data Source
AI summary
Aspects of the invention are directed to mineral-based nanoparticles comprising silicate nanoparticles that induce human mesenchymal stem cells (hMSCs) into a cartilage-lineage through the upregulation of cartilage-specific genes resulting in the transformation of the cell phenotype into that of a chondrocyte, i.e., a cartilage producing cell. The silicate nanoparticles are synthesized through a process where the precipitate of sodium silicate is mixed with one or more elements and compounds and milled into nanoparticles.